SB1431 authorizes the Hawaii Department of Health to establish and administer a Hepatitis Prevention Program focused on hepatitis B and hepatitis C. The program is intended to reduce illness and premature death through public education, improved access to services, health equity efforts, and better collection and reporting of data. The bill also directs the department to create a statewide hepatitis prevention plan that includes screening and support for people seeking care and treatment, and it encourages coordination with other agencies, health care providers, insurers, and community stakeholders.
The bill amends existing law on prenatal hepatitis B screening by preserving the department’s authority to adopt rules for screening pregnant women and follow-up for newborns of hepatitis B carrier mothers, while removing outdated language about providing medications to indigent and medically indigent carrier mothers. It also repeals an obsolete statute concerning implied warranties for blood products and hepatitis, reflecting changes in medical testing and public health practice. Finally, the bill appropriates $545,000 in each of fiscal years 2025-2026 and 2026-2027 and creates three positions in the Department of Health to support implementation.
Impact
SB1431 would add new provisions to chapter 325, Hawaii Revised Statutes, creating a formal statutory basis for a state hepatitis prevention program and requiring a statewide prevention plan. It would expand the Department of Health’s public health role in hepatitis awareness, screening, treatment linkage, and data-driven prevention efforts, while also updating and repealing older hepatitis-related statutes that are no longer aligned with current practice. The bill also commits general fund support and staffing for program administration, making it a direct fiscal and operational expansion of state public health law.
Sentiment
The bill appears to have strong support and little visible opposition. It passed the Senate Health and Human Services Committee, Senate Ways and Means, and conference committees unanimously or near-unanimously, with no recorded dissenting votes in the provided history. The findings section and the bill’s structure suggest a consensus around the need for a coordinated, funded public health response to hepatitis in Hawaii.
Contention
The main policy issue reflected in the bill is not whether hepatitis prevention should be addressed, but how aggressively the state should fund and structure that response. The bill’s emphasis on equity, social determinants of health, and expanded screening and treatment support suggests a broad public health approach, which may raise implementation questions about agency capacity, coordination with providers and insurers, and the adequacy of the appropriation. The repeal of older blood-transfusion language and the removal of obsolete newborn medication language indicate technical cleanup rather than substantive controversy, and no specific opposition is reflected in the available discussion or votes.